ELAN PE Ratio & Valuation, Is ELAN Overvalued

Historical Valuation

Elanco Animal Health Inc (ELAN) is now in the Fair zone, suggesting that its current forward PE ratio of 23.48 is considered Fairly compared with the five-year average of 18.83. The fair price of Elanco Animal Health Inc (ELAN) is between 14.15 to 24.03 according to relative valuation method.

Relative Value

Fair Zone

14.15-24.03

Current Price：23.45

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Elanco Animal Health Inc (ELAN) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Elanco Animal Health Inc (ELAN) has a current Price-to-Book (P/B) ratio of 1.66. Compared to its 3-year average P/B ratio of 1.05, the current P/B ratio is approximately 57.38% higher. Relative to its 5-year average P/B ratio of 1.25, the current P/B ratio is about 33.09% higher. Elanco Animal Health Inc (ELAN) has a Forward Free Cash Flow (FCF) yield of approximately 3.29%. Compared to its 3-year average FCF yield of 3.79%, the current FCF yield is approximately -13.28% lower. Relative to its 5-year average FCF yield of 3.23%, the current FCF yield is about 1.91% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for ELAN competitors is 40.47, providing a benchmark for relative valuation. Elanco Animal Health Inc Corp (ELAN.N) exhibits a P/S ratio of 2.29, which is -94.33% above the industry average. Given its robust revenue growth of 12.16%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of ELAN increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of ELAN in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is ELAN currently overvalued or undervalued?

What is Elanco Animal Health Inc (ELAN) fair value?

ELAN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Elanco Animal Health Inc (ELAN) is between 14.15 to 24.03 according to relative valuation method.

How does ELAN's valuation metrics compare to the industry average?

The average P/S ratio for ELAN's competitors is 40.47, providing a benchmark for relative valuation. Elanco Animal Health Inc Corp (ELAN) exhibits a P/S ratio of 2.29, which is -94.33% above the industry average. Given its robust revenue growth of 12.16%, this premium appears unsustainable.

What is the current P/B ratio for Elanco Animal Health Inc (ELAN) as of Mar 12 2026?

As of Mar 12 2026, Elanco Animal Health Inc (ELAN) has a P/B ratio of 1.66. This indicates that the market values ELAN at 1.66 times its book value.

What is the current FCF Yield for Elanco Animal Health Inc (ELAN) as of Mar 12 2026?

As of Mar 12 2026, Elanco Animal Health Inc (ELAN) has a FCF Yield of 3.29%. This means that for every dollar of Elanco Animal Health Inc's market capitalization, the company generates 3.29 cents in free cash flow.

What is the current Forward P/E ratio for Elanco Animal Health Inc (ELAN) as of Mar 12 2026?

As of Mar 12 2026, Elanco Animal Health Inc (ELAN) has a Forward P/E ratio of 23.48. This means the market is willing to pay $23.48 for every dollar of Elanco Animal Health Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Elanco Animal Health Inc (ELAN) as of Mar 12 2026?

As of Mar 12 2026, Elanco Animal Health Inc (ELAN) has a Forward P/S ratio of 2.29. This means the market is valuing ELAN at $2.29 for every dollar of expected revenue over the next 12 months.

ELAN Valuation